Managing logistics partnerships in uncertain times
Outsourced services can provide significant financial and risk-avoidance benefits
Vaccines manufacturers wrestle with public health policy
Good growth is occurring in the vaccine business, despite the hurdles of public perceptions and public-health funding shortfalls
The impact of the anti-vaccination lobby
Logistics providers confront a complex, global healthcare market
The rise in product volume is more than matched by the rise of regulatory constraints
A new way to look at the performance of passive cold-chain shipping containers
A 'performance curve' chart for containers could simplify the design process
Observational Research: Choosing the right research approach for the right question
Digitized stress analysis improves blister performance
Design analysis can dictate blister composition
Enterprise solutions for cold chain management
Pharma logistics--so what?
Looking at the essential value of well-managed supply chains
Industry hit a record low number of FDA OPDP actions in 2015
Office of Prescription Drug Promotion finds little to complain about
Collaboration key to a healthy supply chain in 2016
HDMA seeks to encourage more outreach to business partners and government
Pharma's bread and butter is still made with powder
Despite a flurry of specialty pharmaceuticals in innovative formats, traditional powder-based dosages will always be a mainstay
A Conversation with Bill Roth, Blue Fin Group
Annual EY Firepower report finds a 'feverish' environment for M&A
Deal value soared above $300 billion in 2015, but will the dealmaking sustain Big Pharma companies?
Problems continue with FDA postmarketing review processes
Industry is doing better at filing studies, but the agency is falling behind reviews, says GAO
New life sciences capital-construction projects totaled $15 billion in 2015
Construction index shows a steady level of North American activity
New year, new names for BIO and Canada's pharma trade association, and more
'Innovation' is the recurring theme
Full-line distributor sales reached $350 billion in 2013, representing 91% of pharma sales
HDMA's 2015-16 Factbook updates member financial, operational performance
Mind your "Q"s: QPharma acquires Qforma
Combination expands breadth of commercialization and compliance services
FDA approved 45 new drugs in 2015--a new recent record
List includes 21 new orphan drugs, and of the 45, 15 are cold chain products
Eagle Pharmaceuticals gets a 505(b)(2) approval for docetaxel
Company partners with Teikoku for the latter's first marketed oncology product, and earns a milestone payment from Teva
